InvestWiser

Isofol Medical AB

ISOFOLNasdaq StockholmHealthcareMarket value 306 m SEK
0.95SEK +0.3%
last day · Price as of 19 November 2026

The answer first

Does Isofol Medical beat the market?

Yes, Isofol Medical has beaten the market over the last year.

Isofol Medical+38.1%Stockholm (OMXSGI)+17.6%
  • The ranking · Quality, value and trend combined

    Better than 67% of Nordic stocks

    • Quality72
    • Value10
    • Trend96

    No. 42 of 195 in healthcare

  • Expectations in the price

    High expectations

    For the share to return about 9% a year from today's price, the cash Isofol Medical keeps must grow about 8% a year for 10 years.

Max for seven days

Follow Isofol Medical with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 19 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on Isofol Medical

From today, at a price of 0.95 SEK. Write why you follow Isofol Medical, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about Isofol Medical

Your first answer is free, no account needed.

Do you own Isofol Medical, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with Isofol Medical and a few more. Free, no card.

Past year against the exchange and Super Stock
Isofol Medical+38.1%Stockholm (OMXSGI)+17.6%Super Stock+46.4%
18 November 202519 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • Isofol Medical has risen 38.1% over the past year, including dividends.
  • Overall, Isofol Medical ranks better than 67% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 97.9%. The price is 95.8% below its peak now.

What do analysts think of Isofol Medical?

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

67

Quality, value and trend together. Better than 67% of Nordic stocks.

No. 42 of 195 in healthcare

Quality72
The company · Fundamentals: the accounts

High A solid company: it earns well on its money and has healthy finances.

No. 79 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity0.00
  • Asset turnoverSales divided by everything the company owns0.00
  • Return on equityProfit divided by equity−66.9%
  • Cash conversionOperating cash flow divided by profit–

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value10
The price · Valuation: the multiples

Low High price: buyers pay a lot today, often because they expect growth.

No. 134 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50

  • P/BPrice divided by equity3.6
  • P/SPrice divided by salesnegative earnings
  • P/EPrice divided by earningsnegative earnings
  • P/CFPrice divided by operating cash flownegative earnings

The ranking is built on P/E, P/B and P/S.

Trend96
The share price · Technical: the price trend

High Tailwind in the share price: it has risen more than most over the last year.

No. 10 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months+15.2%
  • 6 months+36.2%
  • 9 months+63.1%
  • 12 months+38.1%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
−13.7%
3 years, per year
+8.5%
5 years, per year
−36.9%
Year to date
+31.0%
Largest fall, 3 years
−97.9%
From a peak to the bottom
From the peak now
−95.8%
How far the price is from the peak
Volatility, 1 year
77.4%
How much the price swings over a year
Beta, 1 year
0.59
How much the price moves when the market moves

Return with dividends reinvested.

The funds that own Isofol Medical

2 funds we follow own Isofol Medical. The share is how much of the fund the stock makes up.

  • Sweden2

From the funds' latest known holdings.

About Isofol Medical

Isofol Medical AB is a company in healthcare, listed on Nasdaq Stockholm. By market value, Isofol Medical is number 64 of 137 companies in healthcare on Nasdaq Stockholm. Isofol Medical has not paid a dividend in the past twelve months. Of the three measures in the ranking, Isofol Medical is strongest on trend, better than 96% of Nordic stocks. The share trades in SEK. It has around 6 employees.

Isofol Medical AB (publ) operates as a clinical stage biotech company. It develops arfolitixorin, which is in phase Ib/II clinical trial for the treatment of metastatic colorectal cancer. The company was incorporated in 2008 and is based in Gothenburg, Sweden.

See the full analysis of Isofol Medical.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Nasdaq Stockholm

Explore the stock market